4. Celiac…
Definition:
Celiac disease is an immune-mediated
enteropathy
Induced by the ingestion of gluten (present in
wheat, barley, and rye) in genetically susceptible
individuals
Reverts to normal after the exclusion of gluten
from the diet.
6/9/2022 4
5. Celiac…
Epidemiology:
Affects individuals from multiple and diverse ethnic
and racial backgrounds.
The overall prevalence of celiac disease in Europe has
been estimated at 1%, with the highest reported
prevalence of 2.4% in Finland
Some authors have noted a female to male ratio of 2:1,
whereas others have reported equal prevalences in men
and women.
6/9/2022 5
6. Celiac…
Pathogenesis:
The interaction of the water-insoluble protein moiety
(gluten) of certain cereal grains with the mucosa of the
small intestine in susceptible persons is central to the
pathogenesis of celiac disease.
Celiac disease is considered an immune disorder that is
triggered by an environmental agent (gliadin) in
genetically predisposed persons.
The wide spectrum of clinical manifestations is the
result of a complex interplay of varying environmental,
genetic, and immune factors.
6/9/2022 6
7. Celiac…
Pathogenesis:
Gluten as antigen
Model for autoimmune diseases with a defined
environmental trigger
Wheat protein exists in a number of storage forms that can
be categorized into 4 general groups based on solubility
characteristics:
Prolamins (soluble in ethanol),
Glutenins (partially soluble in dilute acid or alkali solutions),
Globulins (soluble in 10% NaCl), and
Albumins (soluble in water)
The term gluten encompasses both the prolamins
and the glutenins
6/9/2022 7
8. Celiac…
Pathogenesis:
The prolamins of wheat are referred to as gliadins
Gliadin can be separated electrophoretically into 4
major fractions and exist as single polypeptide chains
A partially deamidated peptide, consisting of amino
acids 56 to 75 of α-gliadin as a dominant epitope,
responsible for activation of T cells in celiac disease
The release of intracellular tTG leads to the
deamidation of gluten proteins and an enhancement of
T-cell responses to the resulting DGPs
6/9/2022 8
10. Celiac…
Pathogenesis:
Genetic factors
Concordance for celiac disease in first-degree
relatives ranges between 8% and 18% and
estimates for concordance in monozygotic twins
range from 49% to 83%
It is now known that after gluten is absorbed,
lamina propria antigen-presenting cells (probably
dendritic cells) that express HLA-DQ2 or HLA-
DQ8, present gliadin peptides to sensitized T
lymphocytes
6/9/2022 10
11. Celiac…
Pathogenesis:
These lymphocytes then activate B lymphocytes
to generate Igs and other T lymphocytes to secrete
cytokines, including interferon (IFN)-γ,as well as
interleukin (IL)-4, IL-5, IL-6, IL-10, TNF-α, and
transforming growth factor (TGF)-β
These cytokines induce not only enterocyte
injury but also expression of aberrant HLA class
II cell-surface antigens on the luminal surface of
enterocytes, possibly facilitating additional direct
antigen presentation by these cells to the
sensitized lymphocytes
6/9/2022 11
12. Celiac…
Pathogenesis:
Immune factors
Both humoral and cell mediated immune responses to gliadin and
related prolamins in the pathogenesis of celiac disease
IgA antibodies to endomysium, a connective tissue structure
surrounding smooth muscle, are highly specific for celiac disease.
It is now known that the target autoantigen contained within the
endomysium is the enzyme tTG-2.
Gliadin is a preferred substrate for this ubiquitous calcium-
dependent intracellular enzyme, and it has been shown that tTG
deamidates key neutral glutamine residues in gliadin and converts
them into negatively charged glutamic acid residues
6/9/2022 12
13. Celiac…
Pathogenesis:
tTG-mediated modification of gliadin to generate
DGPs plays a pivotal role in eliciting a stronger
proliferative response by gliadin-specific T cells
Activated T lymphocytes, most of which are
CD4+ cells, are abundant in the lamina propria of
the small intestine.
In contrast, IELs, which are present in large
numbers in untreated celiac disease, are
predominantly CD8+ T cells
6/9/2022 13
14. Celiac…
Pathogenesis:
IL-15 regulates IEL homeostasis
Promoting migration, preventing apoptosis, and
enhancing the capacity of dendritic cells to function
as antigen-presenting cells.
In response to gliadin peptides,
IL-15 triggers an adaptive CD4+ T-cell response in
the lamina propria and
also is capable of inducing direct epithelial cell
injury by inducing IEL secretion of IFN-γ
6/9/2022 14
16. Celiac…
Clinical Features:
Celiac disease has protean manifestations of variable
severity that are summarized according to the “celiac
iceberg” model as classical, atypical, silent, or latent
“Classical celiac disease” refers to those patients with
the florid malabsorption syndrome (this group is at the
top of the iceberg).
“Atypical celiac disease” refers to significant but
generally monosymptomatic extraintestinal
manifestations.
6/9/2022 16
17. Celiac…
Clinical…
“Silent celiac disease” refers to the presence of
disease-specific autoimmunity with villous
atrophy in the absence of any symptoms or
apparent consequences.
Potential celiac disease denotes those with
normal small intestinal histology who are at
increased risk of developing celiac disease
(usually identified by positive celiac disease-
specific serology).
6/9/2022 17
18. Celiac…
Clinical…
Nonresponsive celiac disease (NRCD) is defined as ongoing
or recurrent symptoms or signs that suggest active celiac
disease despite a strict GFD for more than 6 to 12 months.
Refractory celiac disease (RCD, a subset of NRCD) is
defined as symptomatic, severe small intestinal villus
atrophy despite a strict GFD for more than 6 to 12 months.
Nonceliac gluten sensitivity refers to symptoms or signs
that develop upon gluten ingestion in people in whom a
diagnosis of celiac disease has been excluded.
6/9/2022 18
19. Celiac…
Clinical…
In the iceberg model, some atypical cases, but
most especially silent and latent celiac disease,
are below the waterline .
Currently, non-classical symptoms are the
clinical presentation in more than 50% of
American patients with celiac disease .
6/9/2022 19
20. Celiac…
Clinical…
Although some patients still present with
severe illness due to significant malabsorption,
many have few, subtle, or no symptoms at
diagnosis
The latter cases may be identified by screening
relatives of patients with celiac disease or from
screening patients with associated disorders,
6/9/2022 20
22. Celiac…
Clinical:
GI Features
Many adults present with GI symptoms including
diarrhea, steatorrhea, abdominal bloating,
flatulence, and weight loss similar to those seen in
childhood celiac disease.
Diarrhea often is episodic rather than continuous.
Nocturnal, early morning, and postprandial
diarrhea are common
6/9/2022 22
23. Celiac…
Clinical…
Severe abdominal pain in celiac disease can suggest the
presence of complications such as intussusceptions,
ulcerative jejunitis, or intestinal lymphoma.
Abdominal distention with excessive amounts of
malodorous flatus is a common symptom.
Symptoms of GERD may be significantly more common in
untreated celiac disease and improve on a GFD.
Recurrent, severe, aphthous stomatitis affects many celiac
patients, may be their sole presenting symptom, and often
resolves on a GFD.
6/9/2022 23
28. Celiac…
Tissue transglutaminase antibodies:
Test by enzyme linked immunosorbent assay is
the screening test of choice for celiac disease
Overall, the tTGA sensitivity is in the range of
95–98% and the specificity >94%
The higher the titer of tissue transglutaminase IgA
antibodies, the greater the likelihood of celiac
disease.
6/9/2022 28
29. Celiac…
Endomysial Antibodies:
EMAs can be measured using an immunofluorescence technique.
The overall sensitivity and specificity using monkey esophagus
as substrate are 97 and 99%, respectively.
The very high specificity makes EMA a very powerful
serologic test, there are some disadvantages:
the test is time consuming
resource-intensive,
requires microscopy and monkey esophagus substrate,
semiquantitative at best,
Highly operator-dependent
6/9/2022 29
31. Celiac…
Histopathology:
Small-bowel biopsy is the confirmatory test for celiac
disease.
Multiple biopsies (ideally four biopsies from the second
part of the duodenum plus two additional biopsies from the
duodenal bulb) are recommended
Histologic findings include:
Increased number of intraepithelial lymphocytes (>25 for 100
epithelial cells),
Villous atrophy,
Crypt hyperplasia.
6/9/2022 31
32. Celiac…
Histopathology…
Biopsies may be classified according to one of several scales
The most common in use by clinicians is the modified Oberhuber–
Marsh scale
Stage I: where there is infiltration of the surface layer by intraepithelial
lymphocytes
Stage II: where in addition to intraepithelial lymphocytes there is
hyperplasia of the crypts
Stage III: Villous atrophy in addition to the other changes.
A sub typing of IIIA, IIIB, and IIIC represents mild villous blunting,
partial villous atrophy, and total villous atrophy.
6/9/2022 32
34. Celiac…
Genetic testing:
Celiac disease is strongly associated with two HLA
haplotypes: DQ2 and DQ8 .
Patients with celiac disease carry at least one of those
two gene pairs (90–95% have DQ2).
Typing of DNA from patients with celiac disease can be
easily performed from whole blood using sequence-
specific primers or allele-specific oligonucleotide
probes
6/9/2022 34
35. Celiac…
Genetic testing…
Though approximately 30–35% of the general
Caucasian population carries either the HLA-DQ2 or
the HLA-DQ8 haplotype,
only a small subset of these subjects have celiac disease
Thus, HLA genotyping in a clinical setting is useful to
practically exclude the diagnosis of celiac disease
especially when the diagnosis is uncertain
6/9/2022 35
38. Celiac…
Treatment:
The management of celiac disease is a lifelong,
medically supervised diet that is devoid of gluten
Voluntary or accidental ingestion of gluten may
occur as a result of
lack of readily available gluten free foods,
eating outside of the home,
cross-contamination (trace amounts of gluten in other
non-gluten-containing foods),
Hidden sources of gluten (e.g., some vitamins and
prescription OTC medications
6/9/2022 38
40. Celiac…
Treatment…
Other important components of the initial
management include the aggressive correction of
dehydration and nutritional deficiencies
All patients require assessment of the Potential
metabolic osteopathy by densitometry.
Temporary restriction of lactose for a period of a
few weeks may be beneficial in some cases .
6/9/2022 40
45. Tropical Sprue
Definition:
Tropical sprue is an acquired disease of unknown
etiology that affects residents and/or visitors of
certain tropical areas
As infectious agents are the most frequent cause
of chronic diarrhea in a tropical environment, the
diagnosis of tropical sprue requires the exclusion
of active infection, especially by protozoa
6/9/2022 45
46. Tropical…
Definition…
Tropical sprue is diagnosed with
malabsorption of at least 2 unrelated nutrient groups
(e.g., fat, carbohydrate, vitamins),
small bowel biopsy findings of mucosal inflammation
and villous shortening,
and
exclusion of the common causes of malabsorption all
had to be present to confirm the diagnosis
6/9/2022 46
47. Tropical…
Epidemiology:
The prevalence of tropical sprue is unknown and
may be different in different locations (e.g., high
prevalence in South India and the Philippines and
very low prevalence in Africa)
The incidence of tropical sprue appears to have
decreased during the past decade,
Improved hygiene and,
Widespread empiric use of antibiotics for the
treatment of chronic diarrhea
6/9/2022 47
48. Tropical…
Pathogenesis:
The etiology of tropical sprue is not known
The favored hypothesis is that tropical sprue is either initiated or
sustained by complex interactions among as yet unidentified
infectious agents, the enterocyte, and the immune system of the host
The host risk factors (e.g., immunologic status, genetics) remain
obscure, as does the specific environmental trigger.
Bacterial overgrowth, disturbed motility, and mucosal injury
contribute to the manifestation of tropical sprue in a susceptible host
.
6/9/2022 48
49. Tropical…
Pathogenesis:
The epidemiology of tropical sprue suggests an
infectious etiology, but extensive investigations
have not yet identified or isolated any consistent
causal agent
“Tropical enteropathy” describes non-specific
changes in the intestine (usually mild
inflammation and partial villous atrophy) of
asymptomatic subjects residing in tropical areas
and should not be confused with tropical sprue.
6/9/2022 49
50. Tropical…
Pathogenesis…
Coliforms (Klebsiella spp., Enterobacter
cloacae, or E. coli) isolated from the small
intestine of patients with TS in Haiti and
Puerto Rico
have been shown to secrete enterotoxins that
damaged the intestinal epithelium in animal
models
6/9/2022 50
52. Tropical…
Clinical features:
TS typically affects adults, although it is also known to
occur in children
The typical presentation is with chronic diarrhea, soreness
of the tongue, and weight loss
The stool may have evidence of steatorrhea, being pale,
bulky, frothy, and foul smelling.
Abdominal distension and borborygmi are prominent
features
6/9/2022 52
55. Tropical…
Diagnosis:
Histologically, small intestinal biopsy specimens in TS
show varying degrees of villous blunting (atrophy), and
crypt elongation.
In addition to blunting, the villi sometimes appear fused.
The normal villous-to-crypt ratio in the jejunal mucosa is
4:1 or 5:1 in the partial villous atrophy seen with TS, this
ratio is reduced to 2:1 or 1:1
In TS, the ileal mucosa usually displays more severe villous
blunting than the duodenal mucosa
6/9/2022 55
57. Tropical…
Diagnosis:
Tropical sprue should be considered in the differential diagnosis of
chronic diarrhea and especially steatorrhea in patients with a recent
history of travel to or residence in tropical areas
The histologic findings are non-specific and may be
indistinguishable from those seen in celiac disease.
The d- xylose test and folic acid levels are usually abnormally low.
Other indirect markers of malabsorption such as
hypoalbuminemia,
prolonged prothrombin time, and a
Low level of β-carotene.
6/9/2022 57
61. Tropical…
Treatment:
Dehydration and electrolyte imbalance must be corrected with appropriate
IV fluids (e.g., full-strength lactated Ringer solution.
In severely malnourished individuals, care must be taken during refeeding
to correct phosphate depletion and prevent the refeeding syndrome which is
caused by rapid refeeding after a long period of undernutrition
The syndrome consists of cardiac (e.g., heart failure, arrhythmias) and
neurologic (e.g., delirium, seizures, neuropathy, ataxia) abnormalities.
Refeeding should commence at 10 kcal/kg/day and increase to 40 kCal/kg/
day over a period of 4 to 7 days.
Thiamine, vitamin B complex, and multi-vitamin supplements should be
started with refeeding
6/9/2022 61
62. Tropical…
Treatment…
Broad-spectrum antibiotics and folic acid are the treatment
of choice
The clinical response is usually rapid (within weeks)
and complete.
Recurrence is uncommon, especially if the patient is
not a resident of or frequent traveler to tropical areas.
Relapses are common in treated patients who return to, or
remain in, tropical areas.
6/9/2022 62
63. Tropical…
Treatment:
Tetracycline is the antibiotic of choice and should be
used for 3–6 months, usually in conjunction with folic
acid
Sulfonamide therapy may be an effective alternative in
patients with allergy or other absolute contraindications
for the use of tetracycline.
A GFD does not result in either clinical or histologic
improvement in tropical sprue.
6/9/2022 63
65. SIBO…
Definition:
SIBO has traditionally been defined by quantitative
culture of aspirated juice from the proximal jejunum.
The most widely accepted definition of SIBO is >105
colony-forming units of bacteria per milliliter of
aspirate (CFU/ mL) aerobic Gram-negative or strict
anaerobic bacteria obtained from a jejunal aspirate
SIBO is typically a byproduct of structural
abnormalities involving the GI tract or alterations in gut
motor, secretory, or immunological function.
6/9/2022 65
66. SIBO…
Pathophysiology:
The quantity and species of bacterial flora vary from
the proximal to distal small intestine.
Normal colony counts are 102 CFU/ mL in the
proximal small intestine, increasing to as high as 109
CFU/ mL in the terminal ileum.
In the proximal small intestine, Gram-positive,
aerobic bacterial species are most common, while
Gram-negative, anaerobic bacteria are more common
distally
6/9/2022 66
67. SIBO…
Pathophysiology…
The normal gut micro flora is maintained by five major
mechanisms:
gastric acid secretion,
pancreatic enzyme secretion,
small-intestinal motility,
structural integrity of the GI tract,
and an intact gut immune system
Disruption of any of these protective mechanisms can
result in the development of SIBO
6/9/2022 67
73. SIBO…
Clinical features:
The clinical consequences of SIBO span a spectrum
ranging from asymptomatic to florid malabsorption.
Most often, affected patients report non-specific
symptoms, including bloating, distension, abdominal
cramping, and diarrhea.
Diarrhea is usually multifactorial, with contributions
from malabsorption, maldigestion,bile acid
deconjugation, protein-losing enteropathy, and co
morbid disease processes
6/9/2022 73
75. SIBO…
Diagnosis:
Aspiration of jejunal fluid for quantitative culture has
been considered the gold standard for the diagnosis of
SIBO
Drawbacks include the
invasive nature of sample collection,
The contamination of aspirated material by oral flora,
The lack of sensitivity for detecting distal SIBO,
the expense, and
the need for infrastructure and trained personnel in order to
perform quantitative culture.
6/9/2022 75
76. SIBO…
DX…
Nowadays, despite being less extensively validated,
endoscopic duodenal sampling has mostly replaced
jejunal aspirates due to its sampling convenience.
During endoscopy,
the appearance of the small bowel is often normal and non-
specific;
villous blunting appears to be the only histopathological
feature seen more frequently in SIBO patients when
compared to controls
6/9/2022 76
77. SIBO…
DX…
Carbohydrate breath tests are used as a surrogate means
of identifying SIBO.
Breath tests rely upon the ability of intestinal bacteria
to metabolize various carbohydrate substrates to
hydrogen and/or methane gas.
Rapid rise in breath hydrogen or methane excretion
may indicate the presence of SIBO
The most commonly used substrates include lactulose
and glucose.
6/9/2022 77
78. SIBO…
DX…
In the absence of SIBO, lactulose is not fermented or
absorbed within the small intestine.
When exposed to bacteria within the small intestine,
lactulose is fermented to short-chain fatty acids and a
number of gases, including hydrogen and methane.
Colonic bacteria will also ferment lactulose, making it
difficult to interpret whether a positive breath test result
truly represents SIBO or simply rapid orocecal transit
6/9/2022 78
79. SIBO…
DX…
The other substrate commonly used to test for SIBO is glucose.
Glucose is avidly absorbed in the proximal small intestine.
Because glucose typically does not reach the distal small bowel,
GBT may be less sensitive than LBT.
Approximately 15–20% of patients (particularly those with
constipation-predominant IBS) can have methanogenic bacteria that
convert hydrogen into methane, yielding a false negative if only
hydrogen breath levels are measured.
6/9/2022 79
83. SIBO…
Treatment…
There are 3 components to the treatment of SIBO:
1. Correcting the underlying potentially causative
disease
2. Addressing any associated nutritional
deficiencies
and
3. Modifying the altered microbiota.
6/9/2022 83
84. SIBO…
Treatment:
Antibiotics are most commonly used to acutely
decontaminate the small intestine
An ideal antibiotic for SIBO should possess activity
against both aerobic and anaerobic enteric bacteria.
A variety of antibiotics have been used to treat SIBO,
including amoxicillin– clavulanic acid,cefoxitin,
ciprofloxacin, norfloxacin,metronidazole, neomycin,
and doxycyclin.
6/9/2022 84
85. SIBO
TX…
Most reports in the literature have recommended courses of 7–14
days.
If a correctable underlying etiology for SIBO can be identified, a
single course of antibiotics may result in a durable clinical response.
When patients have frequent or very severe bouts of SIBO, using
rotating courses of antibiotics every 4–6 weeks can be very
effective.
Concerns over such a strategy include the development of
Clostridium difficile colitis and multidrug-resistant bacterial flora.
6/9/2022 85
86. SIBO…
Treatment…
In a meta-analysis of 10 randomized, placebo-
controlled studies using different antibiotics to
treat SIBO,
Overall breath test normalization rate, which was
the primary outcome measured, was 51.1% for
antibiotics compared with 9.8% for placebo.
Symptom response tended to correlate with breath
test normalization
6/9/2022 86
91. Short Bowel Syndrome(SBS)
Etiology
Pathophysiology
Intestinal Adaptation To Resection
Medical Management
Home Parenteral Nutrition
Complications
Surgical Management
Pharmacologic Enhancement Of Bowel Adaptation
6/9/2022 91
92. SBS…
Definition:
Short-bowel syndrome (SBS) is defined as
malabsorption due to insufficient intestinal surface area,
with an inability to sustain an adequate nutritional, electrolyte, or
hydration status
in the absence of specialized nutritional support.
In adults, it is typically the consequence of extensive bowel
resection, with loss of absorptive surface area.
Over time, the intestine can adapt in order to ensure more
efficient absorption.
6/9/2022 92
93. SBS…
Definition:
Intestinal failure is defined as an inability to sustain an adequate
nutritional, electrolyte, or hydration status in the absence of
specialized nutritional support,
Often seen in patients with SBS,which typically occurs in adults
with less than 200 cm of functional intestine.
The patients at highest risk generally have a
Duodenostomy or jejunoileal anastamosis with less than35 cm of
residual intestine,
jejunocolic or ileocolic anastamosis with less than 60 cm of residual
intestine,
an end jejunostomy with less than 115 cm of residual intestine
6/9/2022 93
96. SBS…
Pathophysiology:
The major consequence of extensive bowel
resection is loss of absorptive surface area, which
results in malabsorption of macro and
micronutrients, electrolytes, and water
The degree of malabsorption is determined by
the length and function of the remaining intestine
the specific portions of small and large intestine
resected, including
whether the colon remains in continuity.
6/9/2022 96
98. SBS…
Pathophysiology:
The length of the small intestine is estimated at 3–8m in
the adult
Nutrient absorption is preserved until more than one-
half of the small intestine is removed
Nutrient absorption may take place at any level of the
small intestine, but crypt morphology and microvillus
enzyme and transporter activity predict a proximal to
distal gradient in absorptive capacity, and as such, most
macronutrients are absorbed in the proximal 100 cm
6/9/2022 98
100. SBS…
Pathophysiology:
Patients with a proximal jejunostomy have rapid gastric
emptying of liquids and rapid intestinal transit
In addition, these patients are net secretors of salt and
fluid, as jejeunal fluid secretion is stimulated by oral
intake and subsequent gastric emptying, so they excrete
more fluid than they ingest
On unrestricted diets, these patients cannot absorb large
volumes of water and electrolytes, and at less than 100
cm of intact jejunum
6/9/2022 100
101. SBS…
Pathphysiology:
The intestine can adapt after bowel resection in order to
ensure more efficient absorption.
These changes are most pronounced in the ileum, which
attains the morphologic characteristics of the jejunum,
with increased villous density and height and an increase
in length.
Conversely, the specialized cells of the terminal ileum,
in which vitamin B12 and intrinsic factor receptors are
located, and in which bile salts are absorbed, cannot be
replaced by jejunal compensation
6/9/2022 101
102. SBS…
Pathophysiology:
These adaptive changes may take up to 2 years to develop
fully, and depend on the presence of food and
biliary/pancreatic secretions.
Because of this, patients with SBS are encouraged to start
oral intake as soon as possible after surgery
In addition, the colon becomes an important digestive organ
in those with SBS.
It has a large reserve absorptive capacity for sodium and
water, and preservation of even part of the colon can
significantly reduce fecal electrolyte and water losses
6/9/2022 102
103. SBS…
Pathophysiology:
Adaptive hyperplasia is the result of an increase in
crypt cell production rate, presumably mediated by
growth factors released by the presence of food and
secretions in the intestinal lumen.
Pharmacologic interventions to accelerate intestinal
adaptation in patients with SBS.
Patients with the highest GLP-2 concentration
following a meal are most likely to be successfully
weaned from PN
6/9/2022 103
104. SBS…
Pathophysiology:
The presence of comorbid conditions and the health of
the residual bowel and its blood flow are important
prognostic factors for patients who have undergone
massive enterectomy.
Plasma citrulline concentration, an indicator of bowel
mass, may be a useful predictor for nutrition autonomy.
Individuals with a plasma citrulline concentration
greater than 20 μmol/L had a 92% sensitivity and 90%
specificity for distinguishing children who gained
independence from PN
6/9/2022 104
107. SBS…
Treatment(Medical)
The most important aspects in the management
of patients with SBS are provision of adequate
nutrition, provision of sufficient fluid and
electrolytes
In the immediate postoperative phase, most
patients with extensive intestinal resections are
kept fasting and are supported with TPN.
6/9/2022 107
108. SBS…
Treatment(Medical)…
Weight and volume status are carefully monitored,
and stomal, fecal, and urinary losses of water, Na+
and K+ are measured
Massive enterectomy is associated with gastric
hypersecretion for the initial 6 months
High doses of oral H2-receptor antagonists,
proton pump inhibitors (PPIs), or IV preparations
due to medication malabsorption.
6/9/2022 108
110. SBS…
Treatment(Medical):
The use of antimotility agents, such as high doses of
loperamide hydrochloride (4–16 mg/day) or diphenoxylate.
If these agents are ineffective, codeine sulfate or tincture of
opium is often necessary.
ORSs improve hydration and decrease PN fluid
requirements, especially in those patients with a proximal
jejunostomy or with less than 100 cm of jejunum remaining
These solutions take advantage of the sodium–glucose Co-
transporter and the solvent drag that follows intracellular
transport of sodium and water
6/9/2022 110
112. SBS…
Treatment(Medical):
Patients who have undergone massive enterectomy
typically require PN initially.
Once they are hemodynamically stable, enteral
nutrition should be started as soon as possible, and
advanced gradually as tolerated.
When patients are able to eat, they should be
encouraged to eat a regular diet and to eat substantially
more than was typical
6/9/2022 112
113. SBS…
Treatment(Medical):
Patients with SBS whose colon is in continuity should
consume a high-complex-carbohydrate diet
Bacteria ferment them into short-chain fatty acids
(SCFAs), including butyrate, proprionate, and acetate.
SCFAs provide fuel for the colonocyte and
significantly reduce fecal energy losses.
sodium and water absorption are stimulated by SCFAs,
6/9/2022 113
114. SBS…
Treatment(Medical)…
Lipid digestion may be impaired, as micelle
formation is limited due to ileal bile salt
malabsorption.
Cholestyramine may be useful in decreasing bile
salt-induced diarrhea in those less than 100 cm of
terminal ileum resected
Regardless of whether the colon is present or
absent, intact protein in a quantity of 1.0 to 1.5
g/kg/day is recommended
6/9/2022 114
115. SBS…
Treatment(Medical):
It is important to assess the vitamin and mineral status
of at regular intervals.
It is unusual for water-soluble vitamin deficiencies to
develop, except in those with duodenostomies or
proximal jejunostomies.
However, folate deficiency may develop in patients with
proximal jejunal resection, and these patients should
receive daily folate.
In addition, vitamin B12 deficiency is seen in patients
who have >60 cm of terminal ileum resected
6/9/2022 115
117. SBS…
Treatment(Medical):
The length of remaining bowel necessary to prevent
dependence on PN is approximately 100 cm in the absence
of an intact colon or 60 cm in the presence of a colon
For those who require long-term PN, gradual attempts
should be made to wean them from PN; approximately 50%
can discontinue PN and resume oral intake after 1–2 years
In addition, treatment with a synthetic analogue of
glucagon-like peptide 2 (GLP 2), an intestinotrophic agent,
was shown to have benefit
6/9/2022 117
120. SBS…
Treatment(Surgical):
Anastamosis of the small bowel to the colon is the most
important surgical procedure, enhancing the ability of the
colon to become an energy-absorptive organ
Longitudinal intestinal lengthening and tailoring (Bianchi
procedure)
The main indication for intestinal transplantation is
PN dependent SBS complicated by progressive liver disease
If patients are referred for evaluation for transplantation prior to
the development of advanced fibrosis,
patients with significant fluid losses and refractory dehydration.
6/9/2022 120
121. SBS…
Prognosis:
The prognosis for patients with SBS depends on the type
and extent of bowel resection, along with the underlying
disease and health of residual intestine.
Patients with small bowel length<50 cm, including those
with high jejunostomies and severe malabsorption, have a
worse prognosis.
Mesenteric infarction and radiation enteritis as a cause for
the bowel resection has a worse prognosis
overall prognosis, including survival and quality of life, is
improving, largely because of increasing experience with
long-term TPN
6/9/2022 121
123. Whipple…
Definition and Epidemiology:
Whipple’s disease is a rare, chronic, systemic
infection caused by Tropheryma whipplei
Whipple’s disease is most common between the
4th and 6th decades of life, with a male
predominance.
It occurs predominantly in Caucasians and is
more common in farmers
6/9/2022 123
124. Whipple…
Pathophysiology:
The symptoms and clinical findings in Whipple’s disease are caused
by chronic infection of the small intestine and other extraintestinal
sites with T. whipplei.
T. whipplei DNA has been found in gastric fluid, saliva, and stool
samples from asymptomatic patients, suggesting that T. whipplei
may be a ubiquitous, commensal organism in the environment.
Immune evasion and host interaction are important in the
pathogenesis of infection.
Defects of monocyte/macrophage function ,plays an important
pathophysiologic role, leading to an inability of the host response to
eliminate the bacteria
6/9/2022 124
125. Whipple…
Pathophysiology…
T. whipplei is a commensal bacterium of humans,
transmitted between humans
May cause acute primary disease followed by acquired
immunity and bacterial clearance
In some people it is not cleared and leads to a healthy
asymptomatic carrier state
It may go on to cause WD, but only in a small subset
of people who lack an adequate immune response
6/9/2022 125
126. Whipple…
Pathophysiology:
The lamina propria of the small-bowel mucosa is
Infiltrated by large, foamy macrophages,
Distort normal villous architecture,
Blunted, club-like appearance.
The cytoplasm of these macrophages is filled with
large glycoprotein granules that stain with PAS.
The lymphatic channels are dilated.
6/9/2022 126
127. Whipple…
Pathophysiology…
Electron microscopy reveals rod-shaped bacillary
bodies in the lamina propria.
The bacilli have a characteristic cell wall and pale
central nucleoid.
The Whipple bacillus is acid-fast-negative.
PAS-positive macrophages and the characteristic bacilli
have been identified in many extraintestinal tissues,
reflecting the systemic nature of the disease.
6/9/2022 127
129. Whipple…
Clinical features:
Some authors have proposed the existence of 3
distinct types of disease:
classic (disseminated and/or intestinal) WD
chronic localized infection, such
endocarditis,isolated CNS disease or uveitis,
without detectable intestinal involvement;
and
Acute transient infections, such as gastroenteritis
or pneumonia.
6/9/2022 129
130. Whipple…
Clinical features:
GI Symptoms
Diarrhea or steatorrhea is the most common
presenting complaint
Other intestinal symptoms include abdominal
bloating, cramps, and anorexia.
Weight loss is the second most common
presenting complaint
6/9/2022 130
131. Whipple…
Clinical features:
Extraintestinal Symptoms
Arthritis is the most common extraintestinal symptom, affecting the
majority of patients
It often develops before the initial diagnosis of Whipple’s disease
and is typically an intermittent, migratory arthritis of both the large
and small joints.
Fever is usually low grade and intermittent
Fatigue and generalized weakness are also common.
T. whipplei is associated with culture-negative infective endocarditis
6/9/2022 131
132. Whipple…
Clinical features:
Neurological Symptoms
Symptoms related to CNS Whipple’s disease are present in a
minority of patients.
Neurological symptoms may occur with GI symptoms or as isolated
symptoms.
The most common CNS symptoms are dementia, paralysis of gaze,
and myoclonus.
Two signs that are indicative of CNS WD are oculomasticatory
myorhythmia and oculofacial skeletal myorhythmia
.
6/9/2022 132
134. Whipple…
Radiologic and Endoscopic Findings:
A small-bowel series typically reveals marked
thickening of the mucosal folds, most prominent
in the proximal small bowel
Abdominal CT often reveals small-bowel
thickening and massive para-aortic and
retroperitoneal adenopathy
On endoscopy, a characteristic finding of pale,
shaggy, yellow mucosa in the postbulbar
duodenum may be seen
6/9/2022 134
135. Whipple…
Laboratory Findings:
Low serum carotene levels,
Hypoalbuminemia,
Electrolyte disturbances,
Anemia is usually present secondary to chronic disease or iron
deficiency
The erythrocyte sedimentation rate is often elevated
Prothrombin time is frequently prolonged
6/9/2022 135
136. Whipple…
Diagnosis:
Small-intestinal mucosal biopsy is the diagnostic test of
choice.
Diagnostic of Whipple disease:
Infiltration of the lamina propria of the small intestine by
PAS-positive macrophages containing
Gram-positive,
acid-fast-negative bacilli
accompanied by lymphatic dilation
Rarely, the diagnosis of Whipple’s disease is established in
the absence of intestinal involvement by the identification
of bacilli in involved tissues.
6/9/2022 136
137. Whipple…
Treatment:
Antibiotic therapy usually results in dramatic
improvement.
Treatment with an antibiotic that readily crosses the
blood–brain barrier (BBB) is appropriate
One double-strength tablet TMP–SMX given twice
daily for 1 year has been proposed to be the optimal
long-term option
Initial therapy with parenteral penicillin G and
streptomycin, ceftriaxone, or meropenem for 10–14
days results in a lower relapse rate
6/9/2022 137
138. Whipple…
Treatment:
Patients may also develop an immune reconstitution
inflammatory syndrome (IRIS), manifested by a high
fever in the first few weeks following initiation of
antibiotics.
This is more common in patients with CNS involvement
and in those who were on extended immunosuppressive
therapy
After 1 year of antibiotic therapy, a small-intestinal
mucosal biopsy should be repeated to document the
absence of residual bacilli.
6/9/2022 138
141. Whipple…
Prognosis:
The prognosis for patients with Whipple’s disease who
receive effective antibiotic therapy is excellent, with
rapid improvement in GI and extraintestinal symptoms.
Relapse of GI symptoms and arthritis may occur early
or late and may respond favorably to further antibiotic
treatment, whereas CNS relapses tend to occur late
If relapse is suspected, small-intestinal biopsy should
be repeated to assess for the presence of free bacilli.
The treatment of relapse of Whipple’s disease is a
repeat course of the initial antibiotic therapy.
6/9/2022 141
142. References
Sleisenger and Fordtrans’ Gastrointestinal and Liver
Disease(11th edition)
Harrison’s Principles of Internal Medicine(20th edition)
Practical Gastroenterology and Hepatology(2nd edition)
Uptodate,2018
Guidelines for management of patients with a short bowel ,J
Nightingale, J M Woodward on behalf of the Small Bowel
and Nutrition Committee of the British Society of
Gastroenterology
N engl j med 367;25 nejm.org December 20, 2012
J Gastroenterol 2020;115:165–178.
https://doi.org/10.14309/ajg.0000000000000501; published
online January 8, 2020
6/9/2022 142